| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Biotrend Cevre ve Enerji Yatirimlari A.S. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺19.93 |
| 52 Week High | ₺26.02 |
| 52 Week Low | ₺16.02 |
| Beta | 0.22 |
| 11 Month Change | -8.41% |
| 3 Month Change | 4.67% |
| 1 Year Change | 7.90% |
| 33 Year Change | 144.06% |
| 5 Year Change | n/a |
| Change since IPO | 282.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIOEN | TR Renewable Energy | TR Market | |
|---|---|---|---|
| 7D | 1.6% | -1.2% | -0.9% |
| 1Y | 7.9% | 26.7% | 72.7% |
Return vs Industry: BIOEN underperformed the TR Renewable Energy industry which returned 28.5% over the past year.
Return vs Market: BIOEN underperformed the TR Market which returned 76% over the past year.
Price Volatility
| BIOEN volatility | |
|---|---|
| BIOEN Average Weekly Movement | 6.8% |
| Renewable Energy Industry Average Movement | 6.1% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in TR Market | 10.2% |
| 10% least volatile stocks in TR Market | 4.8% |
Stable Share Price: BIOEN has not had significant price volatility in the past 3 months.
Volatility Over Time: BIOEN's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 751 | Osman Vardi | www.biotrendenerji.com.tr |
Biotrend Cevre ve Enerji Yatirimlari A.S. engages in the solid waste management and power generation activities in Turkey. It is involved in the landfill gas, biomethanization, biomass, waste disposal, waste separation, waste fuel preparation and supply, steam sales and greenhouse, and compost activities. The company also offers ATY, an alternative solid fuel obtained from the non-recyclable combustible material remaining after the recyclable materials; and carbon certificates.
Biotrend Cevre ve Enerji Yatirimlari A.S. Fundamentals Summary
| BIOEN fundamental statistics | |
|---|---|
| Market cap | ₺9.75b |
| Earnings (TTM) | ₺1.17b |
| Revenue (TTM) | ₺2.24b |
8.5x
P/E Ratio4.5x
P/S RatioIs BIOEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOEN income statement (TTM) | |
|---|---|
| Revenue | ₺2.24b |
| Cost of Revenue | ₺1.97b |
| Gross Profit | ₺268.97m |
| Other Expenses | -₺902.80m |
| Earnings | ₺1.17b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.34 |
| Gross Margin | 12.03% |
| Net Profit Margin | 52.40% |
| Debt/Equity Ratio | 95.0% |
How did BIOEN perform over the long term?
See historical performance and comparison